المؤلفون: Lieber CM; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, USA., Kang H-J; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, USA., Sobolik EB; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA., Sticher ZM; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, USA., Ngo VL; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, USA., Gewirtz AT; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, USA., Kolykhalov AA; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, USA., Natchus MG; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, USA., Greninger AL; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA., Suthar MS; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Plemper RK; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, USA.

المصدر: Journal of virology [J Virol] 2024 Sep 17; Vol. 98 (9), pp. e0090524. Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/drug effects , SARS-CoV-2*/physiology , SARS-CoV-2*/immunology , Antiviral Agents*/therapeutic use , Antiviral Agents*/pharmacology , Immunocompromised Host* , Virus Replication*/drug effects , COVID-19 Drug Treatment* , Viral Load*/drug effects , Mice, Inbred C57BL* , Disease Models, Animal*, Animals ; Mice ; COVID-19/virology ; COVID-19/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; Female ; Humans ; Ritonavir/therapeutic use ; Cytidine/analogs & derivatives ; Hydroxylamines

SCR Organism: SARS-CoV-2 variants

المؤلفون: Tan CJ; Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA., Ilham S; Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA., Willis C; Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA., Kim A; GRAIL, LLC, Menlo Park, CA, USA., Cong Z; GRAIL, LLC, Menlo Park, CA, USA., Brixner D; Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA., Stenehjem D; Department of Pharmacotherapy, College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA.; Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Sep; Vol. 40 (9), pp. 1577-1587. Date of Electronic Publication: 2024 Aug 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Early Detection of Cancer*/methods , Immunocompromised Host* , Neoplasms*/diagnosis , Neoplasms*/epidemiology, Humans ; Middle Aged ; Aged ; Female ; Male ; Population Health ; Mass Screening/methods

المؤلفون: Nates JL; Department of Critical Care Medicine, Division of Anesthesiology, Critical Care, and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pène F; Médecine Intensive et Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Cité, Paris, France., Darmon M; Médecine Intensive et Réanimation, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital and Paris University, Paris, France., Mokart D; Critical Care Department, Institut Paoli Calmettes, Marseille, France., Castro P; Medical Intensive Care Unit, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., David S; Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland., Povoa P; Intensive Care Unit 4, Dept of Intensive Care, Hospital de São Francisco Xavier, ULSLO, Lisbon, Portugal.; NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.; Center for Clinical Epidemiology and Research Unit of Clinical Epidemiology, Odense University Hospital, Odense, Denmark., Russell L; Dept. of Intensive Care Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark.; Dept of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Nielsen ND; University of New Mexico Hospital, Lomas Ave, Albuquerque, NM, USA., Gorecki GP; Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania., Gradel KO; Center for Clinical Epidemiology and Research Unit of Clinical Epidemiology, Odense University Hospital, Odense, Denmark., Azoulay E; Médecine Intensive et Réanimation, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital and Paris University, Paris, France., Bauer PR; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 First Street S.W., Rochester, MN, 55905, USA. Bauer.Philippe@mayo.edu.

مؤلفون مشاركون: Nine-I Investigators

المصدر: Critical care (London, England) [Crit Care] 2024 Aug 30; Vol. 28 (1), pp. 285. Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE

مواضيع طبية MeSH: Shock, Septic* , Immunocompromised Host* , Neoplasms*/complications, Humans

المؤلفون: Rowan CM; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA., LaBere B; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Division of Pulmonology, Section of Allergy-Immunology, Phoenix Children's Hospital, Phoenix, Arizona, USA., Young CC; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., Zambrano LD; Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Newhams MM; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., Kucukak S; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., McNamara ER; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., Mack EH; Division of Pediatric Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Fitzgerald JC; Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Irby K; Section of Pediatric Critical Care, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, Arkansas, USA., Maddux AB; Department of Pediatrics, Section of Critical Care Medicine, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA., Schuster JE; Division of Pediatric Infectious Disease, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA., Kong M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Dapul H; Division of Pediatric Critical Care Medicine, Department of Pediatrics, NYU Grossman School of Medicine, Hassenfeld Children's Hospital at NYU Langone, New York, New York, USA., Schwartz SP; Department of Pediatrics, University of North Carolina at Chapel Hill Children's Hospital, Chapel Hill, North Carolina, USA., Bembea MM; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Loftis LL; Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Kolmar AR; Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA., Babbitt CJ; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Miller Children's and Women's Hospital of Long Beach, Long Beach, California, USA., Nofziger RA; Division of Critical Care Medicine, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio, USA., Hall MW; Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA., Gertz SJ; Division of Pediatric Critical Care, Department of Pediatrics, Cooperman Barnabas Medical Center, Livingston, New Jersey, USA., Cvijanovich NZ; Division of Critical Care Medicine, UCSF Benioff Children's Hospital Oakland, Oakland, California, USA., Zinter MS; Department of Pediatrics, Divisions of Critical Care Medicine and Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, San Francisco, California, USA., Halasa NB; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bradford TT; Division of Cardiology, Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital of New Orleans, New Orleans, Louisiana, USA., McLaughlin GE; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA., Singh AR; Pediatric Critical Care Division, Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla, New York, USA., Hobbs CV; Department of Pediatrics, Division of Infectious Diseases, Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Wellnitz K; Division of Pediatric Critical Care, Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA., Staat MA; Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Coates BM; Division of Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Crandall HR; Division of Pediatric Critical Care, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA., Maamari M; Department of Pediatrics, Division of Critical Care Medicine, University of Texas Southwestern, Children's Medical Center Dallas, Dallas, Texas, USA., Havlin KM; Department of Pediatrics, Division of Pediatric Critical Care Medicine, University of Louisville, and Norton Children's Hospital, Louisville, Kentucky, USA., Schwarz AJ; Division of Critical Care Medicine, Children's Health Orange County (CHOC), Orange, California, USA., Carroll CL; Division of Critical Care, Connecticut Children's Medical Center, Hartford, Connecticut, USA., Levy ER; Divisions of Pediatric Infectious Diseases and Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA., Moffitt KL; Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA., Campbell AP; Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Randolph AG; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Departments of Anaesthesia and Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Chou J; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

مؤلفون مشاركون: Overcoming COVID-19 Investigators

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 395-404.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/mortality , COVID-19*/epidemiology , COVID-19*/therapy , Immunocompromised Host* , Intensive Care Units, Pediatric*/statistics & numerical data , SARS-CoV-2*, Humans ; Child ; Male ; Female ; Adolescent ; Child, Preschool ; Infant ; Hospitalization/statistics & numerical data ; United States/epidemiology ; Hospital Mortality

المؤلفون: Maruki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan., Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: hnomoto@hosp.ncgm.go.jp., Iwamoto N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan., Yamamoto K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan., Kurokawa M; Laboratory Testing Department, National Center for Global Health and Medicine, Tokyo, Japan., Iwatsuki-Horimoto K; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Yamayoshi S; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Suzuki Y; Department of Computational Biology and Medical Sciences, The University of Tokyo, Tokyo, Japan., Kawaoka Y; Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo, Tokyo, Japan; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA., Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Aug; Vol. 30 (8), pp. 793-795. Date of Electronic Publication: 2024 Jan 17.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Immunocompromised Host* , Lymphoma, Follicular*/drug therapy , Lymphoma, Follicular*/immunology , Alanine*/analogs & derivatives , Alanine*/therapeutic use , Adenosine Monophosphate*/analogs & derivatives , Adenosine Monophosphate*/therapeutic use , Adenosine Monophosphate*/administration & dosage , Ritonavir*/therapeutic use , Antiviral Agents*/therapeutic use , Immunoglobulins, Intravenous*/therapeutic use , COVID-19*/immunology , SARS-CoV-2*/immunology , COVID-19 Drug Treatment*, Humans ; Male ; Middle Aged ; Antigens, CD20/immunology ; Treatment Outcome ; Drug Therapy, Combination/methods ; Rituximab/therapeutic use ; Rituximab/administration & dosage ; Viral Load/drug effects ; Antibodies, Monoclonal, Humanized

المؤلفون: Fernández S; Medical Intensive Care Unit, Hospital Clínic of Barcelona, Barcelona, Spain. sfernanm@clinic.cat.; Medical Intensive Care Unit, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. sfernanm@clinic.cat., Grafia I; Medical Intensive Care Unit, Hospital Clínic of Barcelona, Barcelona, Spain.; Department of Medical Oncology, IDIBAPS, Hospital Clinic of Barcelona, Barcelona, Spain., Peyrony O; Emergency Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Department of Infectious Diseases, Hospital Clinic of Barcelona, Barcelona, Spain., Canet E; Service de Médecine Intensive Réanimation, CHU de Nantes, Université de Nantes, Nantes, France., Vigneron C; Médecine Intensive et Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Monet C; Anesthesia and Critical Care Department, St-Eloi Hospital, University of Montpellier, PhyMedExp, INSERM U1046, CNRS, Montpellier, France., Issa N; Medical Intensive Care Unit, Hôpital Saint André, CHU Bordeaux, Bordeaux, France., Decavele M; Medical Intensive Care Unit (Department R3S), Pitié-Salpêtrière University Hospital, Sorbonne University Hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; INSERM Research Unit UMRS1158, Experimental and Clinical Respiratory Neurophysiology, Sorbonne University, Paris, France., Moreau AS; Medical Intensive Care Unit, CHU Lille, Lille, France., Lautrette A; Medical Intensive Care Unit, Jean Perrin Oncology Institut and Montpied Teaching Hospital, Clermont-Ferrand, France., Lacave G; Medical-Surgical Intensive Care Unit, Versailles Hospital Center, Le Chesnay, France., Morel G; Hematology Department, Institut Paoli-Calmettes, Marseille, France., Cadoz C; Réanimation Polyvalente, CHR Metz-Thionville Hôpital de Mercy, Metz, France., Argaud L; Medical Intensive Care Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Statlender L; General Intensive Care Unit, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.; School of Medicine, Tel Aviv University, Tel Aviv, Israel., Azem K; School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Anesthesiology Department, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel., Quenot JP; Deparment of Intensive Care, Burgundy University Hospital, Dijon, France., Lesieur O; Intensive Care Unit, La Rochelle General Hospital, La Rochelle, France., Fernández J; Liver Intensive Care Unit, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; EF-Clif, Barcelona, Spain., Farrero M; Heart Failure Unit, Hospital Clinic of Barcelona, Barcelona, Spain., Marcos MÁ; Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Lemiale V; Medical Intensive Care Unit, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Castro P; Medical Intensive Care Unit, Hospital Clínic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Azoulay É; Medical Intensive Care Unit, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

المصدر: Critical care (London, England) [Crit Care] 2024 Jul 16; Vol. 28 (1), pp. 243. Date of Electronic Publication: 2024 Jul 16.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE

مواضيع طبية MeSH: Cytomegalovirus Infections*/immunology , Immunocompromised Host* , Critical Illness*, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Spain/epidemiology ; Cohort Studies ; Intensive Care Units/statistics & numerical data ; Intensive Care Units/organization & administration ; France/epidemiology ; Adult ; Israel/epidemiology ; Hospital Mortality ; Cytomegalovirus/immunology ; Cytomegalovirus/pathogenicity ; Risk Factors

المؤلفون: Nakagawa N; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Ando T; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Electronic address: takaando-tky@umin.ac.jp., Kawakami M; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Hosoki K; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Hiraishi Y; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Mikami Y; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Kage H; Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

المصدر: Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 726-731. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Bronchoscopy*/methods , Immunocompromised Host* , Immunosuppressive Agents*/administration & dosage, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Lung Diseases/diagnosis ; Adult ; Biopsy/methods ; Aged, 80 and over ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use

المؤلفون: Ajiboye J; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Teixeira JE; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Gasonoo M; Department of Chemistry, Saint Louis University, Room 206 Monsanto Hall, 3501 Laclede Avenue, Saint Louis, MO, USA., Mattice EB; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Korwin-Mihavics B; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Miller P; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Cameron AC; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Stebbins E; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA., Campbell SD; Department of Molecular Microbiology and Immunology, Saint Louis University, Room 316 Doisy Research Center, 1100 South Grand Boulevard, Saint Louis, MO, USA., Griggs DW; Department of Molecular Microbiology and Immunology, Saint Louis University, Room 316 Doisy Research Center, 1100 South Grand Boulevard, Saint Louis, MO, USA., Spangenberg T; Global Health R&D of Merck Healthcare, Ares Trading S.A. (a subsidiary of Merck KGaA, Darmstadt, Germany), Route de Crassier 1, Eysins, Switzerland., Meyers MJ; Department of Chemistry, Saint Louis University, Room 206 Monsanto Hall, 3501 Laclede Avenue, Saint Louis, MO, USA. marvin.j.meyers@slu.edu., Huston CD; Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA. christopher.huston@uvm.edu.

المصدر: Nature communications [Nat Commun] 2024 Sep 27; Vol. 15 (1), pp. 8272. Date of Electronic Publication: 2024 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Cryptosporidium parvum*/drug effects , Cryptosporidiosis*/drug therapy , Cryptosporidiosis*/parasitology , Immunocompromised Host* , Phosphodiesterase Inhibitors*/pharmacology , Phosphodiesterase Inhibitors*/administration & dosage, Animals ; Male ; Mice ; Humans ; Administration, Oral ; Pyrimidines/pharmacology ; Pyrimidines/administration & dosage ; Pyrazoles/pharmacology ; Pyrazoles/administration & dosage ; Molecular Docking Simulation

المؤلفون: Schultz CS; Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA., Gavrancic T; Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.

المصدر: The American journal of case reports [Am J Case Rep] 2024 Sep 27; Vol. 25, pp. e944958. Date of Electronic Publication: 2024 Sep 27.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-5923 (Electronic) Linking ISSN: 19415923 NLM ISO Abbreviation: Am J Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Bacteremia*/microbiology , Bacteremia*/drug therapy , Clostridium Infections*/complications , Clostridium Infections*/diagnosis , Immunocompromised Host* , Pneumonia, Aspiration*/microbiology, Humans ; Male ; Aged ; Clostridium/isolation & purification ; Anti-Bacterial Agents/therapeutic use ; Neutropenia/complications ; Lymphoma, Follicular/complications ; Piperacillin, Tazobactam Drug Combination/therapeutic use

عنوان ترانسليتريتد: Efectividad de tixagevimab/cilgavimab en la reducción de la infección, ingresos hospitalarios y mortalidad por SARS-CoV-2 en pacientes inmunodeprimidos.

المؤلفون: Marti-Pastor M; Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de la Ribera, Valencia, España. Electronic address: mmartip27@gmail.com., Bou-Monterde R; Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de la Ribera, Valencia, España., Ciancotti-Oliver L; Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de la Ribera, Valencia, España., Alcover-Pons M; Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de la Ribera, Valencia, España., Amorós Cantero A; Servicio de Medicina Preventiva y Salud Pública. Hospital Universitario de la Ribera, Valencia, España., Sánchez-Lopezosa R; Servicio de Medicina Interna. Hospital Universitario de la Ribera, Valencia, España., Montañana-Rosell N; Servicio de Medicina Interna. Hospital Universitario de la Ribera, Valencia, España.

المصدر: Medicina clinica [Med Clin (Barc)] 2024 Sep 27; Vol. 163 (6), pp. 275-280. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE

مواضيع طبية MeSH: Hospitalization*/statistics & numerical data , Immunocompromised Host* , COVID-19*/prevention & control , COVID-19*/mortality , COVID-19*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19 Drug Treatment ; SARS-CoV-2 ; Propensity Score